DIFFERENTIAL LABELING OF DOPAMINE-RECEPTORS IN RAT-BRAIN INVIVO - COMPARISON OF [H-3]-LABELED PIRIBEDIL, [H-3]-LABELED S-3608 AND [H-3]N,NORMAL-PROPYLNORAPOMORPHINE

被引:30
作者
HALL, MD
JENNER, P
MARSDEN, CD
机构
[1] UNIV LONDON,KINGS COLL HOSP,SCH MED,DEPT NEUROL,LONDON SE5 8AF,ENGLAND
[2] UNIV LONDON KINGS COLL HOSP,SCH MED,RAYNE INST,LONDON SE5 8RX,ENGLAND
关键词
D O I
10.1016/0014-2999(83)90053-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:85 / 94
页数:10
相关论文
共 15 条
[1]   RESPONSES OF CENTRAL NEURONS TO PIRIBEDIL AND 2-BROMO-ALPHA-ERGOCRYPTINE - COMPARISON WITH DOPAMINE AND APOMORPHINE [J].
BIOULAC, B ;
FUMOUX, F ;
FERRON, A ;
VINCENT, JD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (01) :29-37
[2]   EVIDENCE FOR A NEW TYPE OF DOPAMINE RECEPTOR STIMULATING AGENT [J].
CORRODI, H ;
UNGERSTEDT, U .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (12) :989-+
[3]   SITE AND MODE OF ACTION OF ET495 FOR MEDIATION OF STEREOTYPED BEHAVIOR IN RAT [J].
COSTALL, B ;
NAYLOR, RJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 278 (02) :117-133
[4]   N-N-PROPYLNORAPOMORPHINE-H-3 - NOVEL AGONIST LIGAND FOR CENTRAL DOPAMINE RECEPTORS [J].
CREESE, I ;
PADGETT, L ;
FAZZINI, E ;
LOPEZ, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 56 (04) :411-412
[5]  
FUXE K, 1980, NEUROSCI LETT S, V5, pS98
[6]   PRELIMINARY INVESTIGATION OF METABOLISM OF PIRIBEDIL (AND 495) - NEW CENTRAL DOPAMINERGIC AGONIST AND POTENTIAL ANTI-PARKINSON AGENT [J].
JENNER, P ;
TAYLOR, AR ;
CAMPBELL, DB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (09) :749-750
[7]   REGIONAL INVIVO BINDING OF [N-PROPYLNORAPOMORPHINE-H-3 IN THE MOUSE-BRAIN - EVIDENCE FOR LABELING OF CENTRAL DOPAMINE-RECEPTORS [J].
KOHLER, C ;
FUXE, K ;
ROSS, SB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 72 (04) :397-402
[8]   SPIPERONE - LIGAND OF CHOICE FOR NEUROLEPTIC RECEPTORS .1. KINETICS AND CHARACTERISTICS OF INVITRO BINDING [J].
LEYSEN, JE ;
GOMMEREN, W ;
LADURON, PM .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (03) :307-316
[10]  
Lieberman A N, 1975, Adv Neurol, V9, P399